Recall D-0189-2025

US Class II Ongoing · initiated 2024-12-30

Recalling firm

Rising Pharma Holding, Inc., NJ

Product

Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60

Reason for recall

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

← All recalls